Laia Simó‐Riudalbas

This study shows CDK4 inhibits TNBC cell migration by phosphorylating Myo9b, which suppresses RhoA signaling, and suggests targeting Myo9b-RhoA could improve CDK4/6 inhibitor therapy.

This study identifies POU5F1B as a human-specific oncoprotein that enhances cell invasiveness via plasma membrane remodeling through ubiquitination and S-acylation.

The paper shows that the KZFP/KAP1 system dynamically regulates TEeRS in adult human T cells, affecting gene expression and chromatin states.